dichlorphenamide has been researched along with Hyperkalemia in 2 studies
Dichlorphenamide: A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.
diclofenamide : A sulfonamide that is benzene-1,3-disulfonamide in which the hydrogens at positions 4 and 5 are substituted by chlorine. An oral carbonic anhydrase inhibitor, it partially suppresses the secretion (inflow) of aqueous humor in the eye and so reduces intraocular pressure. It is used for the treatment of glaucoma.
Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral dichlorphenamide (Keveyis™) is a carbonic anhydrase inhibitor that is approved in the USA for the treatment of primary hyperkalaemic and hypokalaemic periodic paralyses and related variants." | 2.53 | Dichlorphenamide: A Review in Primary Periodic Paralyses. ( Greig, SL, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greig, SL | 1 |
| Wakabayashi, Y | 1 |
1 review available for dichlorphenamide and Hyperkalemia
| Article | Year |
|---|---|
Dichlorphenamide: A Review in Primary Periodic Paralyses.
Topics: Carbonic Anhydrase Inhibitors; Clinical Trials, Phase III as Topic; Cross-Over Studies; Dichlorphena | 2016 |
1 other study available for dichlorphenamide and Hyperkalemia
| Article | Year |
|---|---|
Hyperkalaemia induced by carbonic anhydrase inhibitor.
Topics: Acidosis; Acute Kidney Injury; Aged; Aged, 80 and over; Aldosterone; Dichlorphenamide; Glaucoma; Hum | 1991 |